A Novel Method for the Determination of Ganciclovir Triphosphate in Human Red Blood Cells by LC-MS/MS
Journal of Mass Spectrometry and Advances in the Clinical Lab · 29.05.2026 · 39 (1)
DOI: 10.21627/6wt6r959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Mass Spectrometry and Advances in the Clinical Lab, online erschienen am 29.05.2026. Verfasst von Qiao-Lan Xuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: Ganciclovir (GCV) and its prodrug valganciclovir (VGCV) are commonly used to prevent and treat cytomegalovirus (CMV) infections in solid organ transplant recipients. Because of high interindividual pharmacokinetic variability, therapeutic drug monitoring (TDM) is important for optimizing therapy. Ganciclovir-triphosphate (GCV-TP), the active intracellular metabolite, is linked to both efficacy and toxicity; however, clinical monitoring is limited by analytical challenges. OBJECTIVES: To develop and validate a simple and sensitive liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for quantifying GCV-TP in human red blood cells (RBCs). METHODS: GCV-TP was extracted using protein precipitation, separated on a BioBasic AX column, and detected with tandem mass spectrometry using guanosine-13C10-5′-triphosphate as the internal standard. RESULTS: The assay was linear over 0.01–2.00 μg/mL (r2 ≥ 0.99), with intra- and inter-assay variability ≤7.99%. GCV-TP in RBC lysate was stable when stored at room temperature for 4 h or at 4 °C for 24 h. This method was applied to RBC samples from 27 renal transplant recipients receiving VGCV, with a median GCV-TP concentration of 180.8 pmol/8 ×109 RBC (IQR: 113.6–297.6 pmol/8 ×109 RBC). GCV-TP levels showed a significant correlation with VGCV dose (p = 0.020, r = 0.31) but not with plasma GCV concentrations (p > 0.05). CONCLUSION: This validated method enables reliable measurement of intracellular GCV-TP and may serve as a useful tool to support individualized VGCV therapy and pharmacodynamic monitoring in clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
- Institute of Precision Medicine, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Organ Transplant Center, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Zitieren
APA
Xuan, Q. L., Zheng, J. T., Yan, J. J., Liu, L. S., Meng, J. F., Chen, P., Chen, J., Chen, X., Huang, M., Tang, K. J., Wang, C. X., & Zhu, X. (2026). A Novel Method for the Determination of Ganciclovir Triphosphate in Human Red Blood Cells by LC-MS/MS. Journal of Mass Spectrometry and Advances in the Clinical Lab, 39(1). https://doi.org/10.21627/6wt6r959
Vancouver
Xuan QL, Zheng JT, Yan JJ, Liu LS, Meng JF, Chen P, et al. A Novel Method for the Determination of Ganciclovir Triphosphate in Human Red Blood Cells by LC-MS/MS. Journal of Mass Spectrometry and Advances in the Clinical Lab. 2026;39(1). doi:10.21627/6wt6r959
BibTeX
@article{Xuan2026,
author = {Xuan, Qiao-Lan and Zheng, Jun-Tao and Yan, Jia-Jia and Liu, Long-Shan and Meng, Ji-Feng and Chen, Pan and Chen, Jie and Chen, Xiao and Huang, Min and Tang, Ke-Jing and Wang, Chang-Xi and Zhu, Xia},
title = {A Novel Method for the Determination of Ganciclovir Triphosphate in Human Red Blood Cells by LC-MS/MS},
journal = {Journal of Mass Spectrometry and Advances in the Clinical Lab},
year = {2026},
volume = {39},
number = {1},
doi = {10.21627/6wt6r959}
}
EUVIMED